After transfecting with VEGF-promoter reporter and mAkt plasmids, VEGF transcriptional activation was significantly reduced by nobiletin treatment in both ovarian cancer cell types, and this effect was significantly reversed by forced expression of Akt protein (Fig. 6B). Here, VEGFA is linked to ovarian cancer.